Literature DB >> 24880069

HPV integration detection in CaSki and SiHa using detection of integrated papillomavirus sequences and restriction-site PCR.

Rachel Raybould1, Alison Fiander2, Gavin W G Wilkinson3, Sam Hibbitts2.   

Abstract

Human Papillomavirus (HPV) infection is the primary cause of cervical neoplasia. HPV DNA is integrated into the human genome in the majority of cervical cancers. The nature of integration may differ with integration incorporating a single copy of HPV or occurring in concatenated form. Our understanding of HPV tumorigenesis is largely based on studies using characterised cell lines with defined integration sites; these cell lines provide an invaluable standard for validation of diagnostic assays. Cell lines also further understanding of integration mechanisms in clinical samples. The objective of this study was to explore integration assays and to investigate integration events in cell lines where HPV is integrated in concatenated form. Restriction site PCR and detection of integrated papillomavirus sequences were performed on DNA from SiHa and CaSki. A novel integration site on Xq27.3 and HPV genome rearrangements were detected in CaSki DNA. However, where integration was previously detected by FISH in CaSki, and reported to be integrated in concatenated form, integration was not detected by DIPS or RS-PCR. The data presented illustrate that HPV copy number can hinder integration detection; this needs consideration when interpreting results from tests applied to clinical samples.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CaSki; Cervical cancer; Human papillomavirus; SiHa; Viral integration

Mesh:

Year:  2014        PMID: 24880069     DOI: 10.1016/j.jviromet.2014.05.017

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  6 in total

1.  Analysis of human papilloma virus type 52 integration status in exfoliated cervical cells.

Authors:  Ke Zhang; Zhanjun Liu; Ji Li; Juan Li; Jianghong Yan; Yunchuan Su; Shuying Li; Jintao Li
Journal:  Exp Ther Med       Date:  2017-10-11       Impact factor: 2.447

2.  Human myoma tissue-based extracellular matrix models for testing the effects of irradiation on the HPV positive cells.

Authors:  Heidi Tuominen; Ahmed Al-Samadi; Tuula Salo; Jaana Rautava
Journal:  Virol J       Date:  2020-06-30       Impact factor: 4.099

Review 3.  The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications.

Authors:  Zheng Hu; Ding Ma
Journal:  Cancer Med       Date:  2018-09-14       Impact factor: 4.452

4.  hnRNP E1 Regulates HPV16 Oncogene Expression and Inhibits Cervical Cancerization.

Authors:  Li Song; Rui Mao; Ling Ding; Zhiqiang Tian; Mingxuan Zhang; Jiahao Wang; Ming Wang; Yuanjing Lyu; Chunliang Liu; Meijuan Feng; Haixia Jia; Jintao Wang
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738

5.  Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.

Authors:  Ying Liu; Zheming Lu; Ruiping Xu; Yang Ke
Journal:  Oncotarget       Date:  2016-02-02

6.  Genome-wide profiling of the human papillomavirus DNA integration in cervical intraepithelial neoplasia and normal cervical epithelium by HPV capture technology.

Authors:  Ying Liu; Chaoting Zhang; Weijiao Gao; Limin Wang; Yaqi Pan; Yunong Gao; Zheming Lu; Yang Ke
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.